Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 825 of 1,261

  1. US 8680082

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  2. US 8679476

    Interferon-β production modulating Listeria strains and methods for using same

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  3. US 8679545

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  4. US 8679557

    Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma

    SENTISS PHARMA PRIVATE LIMITED · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  5. US 8679510

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  6. US 8680058

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  7. US 8680132

    Spiro-oxindole MDM2 antagonists

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  8. US 8680094

    1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions

    The Board of Regents of the University of Texas System · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  9. US 8680113

    BMI-1 protein expression modulators

    PTC THERAPEUTICS, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  10. US 8680115

    Tetrahydroquinoline analogues as muscarinic agonists

    ACADIA Pharmaceuticals Inc. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  11. US 8680131

    Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

    Jenrin Discovery, LLC · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  12. US 8680150

    Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

    Ligand Pharmaceuticals Incorporated · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  13. US 8680263

    Carbohydrate-based drug delivery polymers and conjugates thereof

    Nektar Therapeutics · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  14. US 8680291

    Diarylhydantoin compounds

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  15. US 8680319

    Method for producing antifolate agents having glutamic acid part in their structure

    Kocak Farma Ilac ve Kimya Sanayi A.S. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  16. US 8680083

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  17. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  18. US 8673858

    Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda

    Soricimed Biopharma Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  19. US 8673843

    NMDA receptors modulators and uses thereof

    Northwestern University · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  20. US 8673375

    Herbal extract products and methods

    Prime Interaction Holdings Limited · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  21. US 8673332

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  22. US 8673333

    Cross-linked polymer matrices, and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  23. US 8673301

    YKL-40 monoclonal antibody

    The Regents of the University of California · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  24. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.